Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study

Published:2019 Issue:3 Volume:60 Page:195
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Kwon Whi-An¹,Joung Jae Young²,Lee Jung Eun²,Choi Se Young³,Kim Sung Han²,Seo Ho Kyung²,Lee Kang Hyun²,Kim Choung-Soo⁴^ORCID

Affiliation:

1. Department of Urology, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea.

2. Department of Urology, Urological Cancer Center, National Cancer Center, Goyang, Korea.

3. Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

4. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

National Cancer Center

Publisher

The Korean Urological Association

Subject

Urology

Link

https://synapse.koreamed.org/pdf/10.4111/icu.2019.60.3.195

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study;Journal of Urologic Oncology;2024-03-31

2. Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice;Yonsei Medical Journal;2023

3. A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer;BMC Cancer;2021-11-29

4. Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation Therapy;Journal of Oncology;2021-08-26

5. Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer;Journal of Cancer Research and Clinical Oncology;2021-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3